Brief: Insmed Incorporated - Launches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases
15/10/2026 13:54
BRIEF-Insmed Incorporated - Launches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases Oct 15 (Reuters) - Insmed Incorporated INSM.O:
INSMED INCORPORATED - LAUNCHES FOUR PIVOTAL PHASE 3 STUDIES FOR TPIP IN PULMONARY DISEASES
INSMED INCORPORATED - THREE PHASE 3 STUDIES INITIATED; FOURTH TO BEGIN IN FIRST HALF OF 2027
Source text: ID:nPnRBVg6a
Further company coverage: INSM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insmed Incorporated
See all newsBrief: Insmed Launches Brinsupri® Tablets 25 Mg (Brensocatib Hydrate) For The Treatment Of Non-Cystic Fibrosis Bronchiectasis In Japan
Brief: Insmed Incorporated - Launches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases
U.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
Insmed CFO Sara Bonstein steps down; shares fall
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector